Biocon Q1 Results: Board meeting set for Aug 5 to approve Q1FY27 numbers
Biocon Limited will approve its Q1FY27 un-audited standalone and consolidated results on August 5, 2026. An earnings call is scheduled for August 6, 2026, at 10:00 hrs IST. The trading window remains closed until August 7, 2026, as per SEBI insider trading regulations.
*this image is generated using AI for illustrative purposes only.
Biocon Limited will announce its financial results for the first quarter of FY27 on Wednesday, August 05, 2026, following a scheduled meeting of its Board of Directors. The company will subsequently host an earnings conference call for analysts and investors on Thursday, August 06, 2026, at 10:00 hrs IST to discuss the performance for the quarter ended June 30, 2026. This disclosure ensures market participants have timely access to management commentary alongside the financial data.
The Board meeting, held pursuant to Regulation 29(1) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, will approve both standalone and consolidated un-audited results. Alongside the financial approvals, the Board will address other routine matters. The company has notified the Bombay Stock Exchange (BSE) and the National Stock Exchange of India Limited (NSE) regarding these proceedings.
In compliance with the Code of Conduct for Prevention of Insider Trading and the SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in Biocon’s securities has been closed. The blackout period commenced on Wednesday, July 01, 2026, and will remain in effect until Friday, August 07, 2026, inclusive. Trading will resume on Saturday, August 08, 2026.
The earnings conference call will be conducted over Zoom. Participants are advised to join ten minutes prior to the scheduled start time. Detailed registration information is available on the company’s investor relations website. Following the call, an audio recording will be accessible before the next trading day or within 24 hours, whichever is earlier. A video recording will be available within 48 hours.
| Event | Date | Time | Platform |
|---|---|---|---|
| Board Meeting | August 05, 2026 | N/A | In-person/Virtual |
| Earnings Call | August 06, 2026 | 10:00 hrs IST | Zoom |
| Trading Window Opens | August 08, 2026 | Market Open | BSE/NSE |
Transcripts of the conference call will be published on the company’s website within five working days of its conclusion. All recordings and transcripts can be accessed under the Financial Information section of the Investor Relations page. For further inquiries, investors may contact Prashant Nair from the Investor Relations team.
Regulatory Disclosures
The intimation was signed by Rajesh U. Shanoy, Company Secretary and Compliance Officer, on July 28, 2026. The company includes a safe harbor statement noting that forward-looking statements made during the call involve risks and uncertainties. These include general economic conditions, R&D efforts, currency fluctuations, interest rate changes, and regulatory shifts in the biotechnology and pharmaceuticals sectors. Neither Biocon nor its directors assume an obligation to update these forward-looking statements.
Historical Stock Returns for Biocon
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.87% | -0.93% | +4.14% | +18.40% | +11.61% | +13.94% |
How might Biocon's Q1 FY27 performance reflect the commercial traction of its recent biologic portfolio expansions?
What specific R&D milestones or pipeline updates are investors likely to prioritize during the August 6 earnings call?
Could the extended trading blackout period indicate significant strategic announcements beyond routine financial results?
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
